Pre-analytical blood sample haemolysis is a subject that's well researched. As much as it's known that haemolysis could be physiological (in vivo), evidence does show mechanical (in vitro) haemolysis is high but could be prevented in most cases through proper sample collection, handling and transportation. Despite the available evidence that's including systematic review, why are we still failing to reduce pre-analytical rate to the acceptable benchmark of 2% or below?